Boston Scientific Corp (BSX)vsLumexa Imaging Holdings, Inc. Common Stock (LMRI)
BSX
Boston Scientific Corp
$48.55
-0.32%
HEALTHCARE · Cap: $70.87B
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$7.77
+3.46%
HEALTHCARE · Cap: $816.69M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 1900% more annual revenue ($20.61B vs $1.03B). BSX leads profitability with a 17.3% profit margin vs -3.7%. BSX earns a higher WallStSmart Score of 76/100 (B+).
BSX
Strong Buy76
out of 100
Grade: B+
LMRI
Hold36
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.4%
Fair Value
$37.35
Current Price
$48.55
$11.20 premium
Intrinsic value data unavailable for LMRI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Reasonable price relative to book value
Areas to Watch
No major concerns identified
3.1% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 3.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : LMRI
The strongest argument for LMRI centers on Price/Book.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : LMRI
The primary concerns for LMRI are Revenue Growth, EPS Growth, Market Cap. Debt-to-equity of 1.61 is elevated, increasing financial risk.
Key Dynamics to Monitor
BSX profiles as a mature stock while LMRI is a turnaround play — different risk/reward profiles.
BSX is growing revenue faster at 11.6% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (76/100 vs 36/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Lumexa Imaging Holdings, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company is headquartered in Raleigh, North Carolina.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?